Reach Us +44-1202-068036
Editor - Raffaele Pilla | University of Salerno | 21997
ISSN: 2472-0895

Epilepsy Journal
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Raffaele Pilla

Raffaele Pilla
Raffaele Pilla
St. John of God Hospital
Benevento, Italy
University of Salerno
University of Salerno


Raffaele Pilla, Pharm.D., Ph.D., Doctor Europaeus, received his Master’s degree in Pharmacy at D’Annunzio University in Chieti, Italy in 2005, where he also served internships at the Cell Physiology and Molecular Biology Laboratories. He received his Doctor Europaeus in 2010 at Pitié-Salpétrière Institute in Paris, France. In 2010, he achieved his Ph.D. in Biochemistry, Physiology, and Pathology of Muscle at D’Annunzio University in Chieti, Italy. Later, he was hired as a Postdoctoral Scholar in the Department of Pharmacology and Physiology at the University of South Florida in Tampa, Florida on two research grants respectively funded by the Office of Naval Research (US Navy) and Divers’ Alert Network. Dr. Pilla has also been involved in ongoing research on the use of ketone esters. He has widely written and lectured internationally. Dr. Pilla is currently working as a pharmacist in Benevento, Italy and as a clinical research coordinator between USA and Italy.

Research Interest

Neurology - Epilepsy - Brain Cancers - Metastatic Cancers - Ketone Esters adopted in the metabolic treatment of epilepsy and cancer - Ketogenic Diet administered in patients affected by epilepsy and cancer - Alzheimer’s disease - Glut 1 deficiency syndrome - Traumatic brain injury - Hyperbaric/hypobaric physiology - Hyperbaric/hypobaric chamber.


The Ketogenic Diet Approach as Metabolic Treatment for a Variety of Diseases

Raffaele Pilla
Editorial: J Epilepsy 2016
DOI: 10.4172/2472-0895.1000e110
Leave Your Message 24x7